UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001090
Receipt No. R000001119
Scientific Title Randomized Phase III Study of Adjuvant Endocrine-Therapy with or without Chemotherapy for Postmenopausal Breast Cancer Patients who Responded to Neoadjuvant Letrozole
Date of disclosure of the study information 2008/03/20
Last modified on 2018/10/12 13:35:22

No. Disposal Last modified on Item of update
1 Insert 2008/03/19 19:37:12
2 Update 2008/12/15 21:32:20

3 Update 2008/12/15 21:32:43 Anticipated trial start date
Last follow-up date
4 Update 2009/09/01 15:03:58 Recruitment status
5 Update 2010/05/11 10:58:36 Address
6 Update 2010/11/01 11:17:56 UMIN ID1
7 Update 2010/11/01 11:25:58 Email
8 Update 2010/12/20 10:12:54 Genomic information
9 Update 2010/12/24 14:37:55 Key inclusion criteria
Key inclusion criteria
10 Update 2011/06/28 10:02:32 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
TEL
Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
11 Update 2011/06/28 11:58:49 Address
Address
Email
12 Update 2011/09/05 09:59:20 Organization
13 Update 2012/09/10 11:06:40 Target sample size
14 Update 2012/09/10 11:07:57 Last name of contact person
Last name of contact person
15 Update 2012/09/10 11:32:46 Name of person sending information
Name of person sending information
16 Update 2013/05/31 13:49:17 Organization
Organization
Organization
17 Update 2013/06/13 14:22:47 Recruitment status
18 Update 2013/06/17 09:20:41 Last name of contact person
Last name of contact person
Name of person sending information
Name of person sending information
19 Update 2013/06/17 09:21:31 Anticipated trial start date
Last follow-up date
20 Update 2013/06/18 11:43:17 Anticipated trial start date
Last follow-up date
21 Update 2016/02/19 14:45:58 TEL
Email
Division name
Division name
22 Update 2017/08/22 13:50:10 Name of primary sponsor
Organization
Institutions
23 Update 2018/10/12 13:35:22 Public title


Contact us.